Clin2
NCT05890781Possibly a fitRecruiting

Study pediatric cancer using lab-made immune organoids

Brain TumorKidney TumorNeuroblastomaSarcoma

Treatments studied

Part of Brain & nervous system, Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial uses special lab models (“immune organoids”) to study certain cancers in children and young people. It may help researchers learn what those cancers do and improve future treatment ideas.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
108 people
Ages
Up to 25 years
Study type
Interventional

Who can take part

  • You were diagnosed at age 25 or younger (with exceptions for some brain and kidney tumor types)
  • You have or are being evaluated for one of these: brain tumor, kidney (renal) tumor, neuroblastoma, or sarcoma
  • Your tumor type must match one of the cancers listed (other cancer types are not eligible)
  • You (and your parent/guardian if needed) can understand the study and sign consent, and you can attend study visits
  • You are part of the French social security system (or a beneficiary of it)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01109394Recruiting
Help study tumors with sample testing and a research biology library

This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.

Washington D.C., District of Columbia
NCT05375617Recruiting
Study for newly diagnosed childhood cancers in Europe

This study follows children and teens with newly diagnosed certain leukemia (ALL) and certain favorable brain tumors to learn best care and outcomes. It may help your team compare standard treatments and monitor health over time.

New York, New York
NCT01868490Enrolling by invitation· Phase 1/Phase 2
Testing a patient’s immune cells for advanced solid tumors

This trial tests a modified version of your own immune cells (made from your blood) to help treat advanced cancers that are no longer responding to standard treatment. It’s designed mainly to see if the approach is safe and how well it may work for people whose disease has progressed.

Bangkoknoi, Bangkok
NCT05481502Recruiting
Study looks at immune markers after cell therapy

This study collects immune and tumor-related samples to learn what predicts response to adoptive cell therapy (a treatment using immune cells). If you (or your child) are eligible, you may help researchers understand who benefits and why.

Villejuif, Val De Marne
NCT07029100Not yet recruiting
Organoids for brain tumors: testing treatment response in the lab

This study tests a new way to grow miniature versions of your brain tumor in the lab (called organoids) from a small piece of your tumor removed during surgery. The results may help doctors understand which treatments might work best for you in the future.

Le Havre
NCT01050296Recruiting
Study of tumor samples to guide treatment for childhood cancers

This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.

Memphis, Tennessee

Hear when a new Brain Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.